Adaptilens
Irvine, United States· Est.
The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.
Private Company
Total funding raised: $4M
About
The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.
OphthalmologyMedical Devices
Funding History
1Total raised:$4M
Seed$4M